NRXP logo

NRXPNRX Pharmaceuticals Inc

$3.98
$0.16
(4.25%)
Today
Closed $3.92
$0.0574
(1.46%)
After Hours
Updated: 07:14 PM EDT
Reported EarningsMay 15
Mkt Cap$157.71M
Vol743,516.00
45

Neutral Sentiment

How do you feel about NRXP?

News
all
press releases
NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why
NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise capital for growth and operations.read more...
Benzinga
News Placeholder
More News
News Placeholder
NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates
NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +20.00% and -91.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, with a loss of 11 cents per share. FDA clearance received for clinical trial.read more...
Benzinga
News Placeholder
D. Boral Capital Reaffirms Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP)
D. Boral Capital restated a 'buy' rating and issued a $34.00 price objective on shares of NRx Pharmaceuticals in a research note on Tuesday...
MarketBeat
News Placeholder
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Large Growth in Short Interest
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling...
MarketBeat
News Placeholder
Equities Analysts Offer Predictions for NRXP Q1 Earnings
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 earnings estimates for NRx Pharmaceuticals in a note issued to investors on Monday...
MarketBeat
News Placeholder
NRx Pharmaceuticals (NASDAQ:NRXP) Earns "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $45.00 price target on shares of NRx Pharmaceuticals in a report on Monday...
MarketBeat
News Placeholder
NRx Pharmaceuticals (NASDAQ:NRXP) Price Target Raised to $49.00 at Ascendiant Capital Markets
Ascendiant Capital Markets lifted their price target on shares of NRx Pharmaceuticals from $48.00 to $49.00 and gave the stock a "buy" rating in a research note on Monday...
MarketBeat
News Placeholder
NRx Pharmaceuticals' (NRXP) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital restated a "buy" rating and set a $34.00 target price on shares of NRx Pharmaceuticals in a research note on Monday...
MarketBeat
News Placeholder
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from Analysts
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. One...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.